Abstract: One aspect of the present disclosure is a manufacturing method for a support piece used in the formation of a dolmen structure in a semiconductor device, including processes of: (A) preparing a laminate film including a base material film, an adhesive layer, and a support piece formation film, for example, including a thermosetting resin layer, in this order; and (B) forming support pieces on a surface of the adhesive layer by singulating the support piece formation film, in which the process (B) includes a process of forming a cut in the support piece formation film partway in a thickness direction, and a process of singulating the support piece formation film in a cooled state by expansion, in this order.

Abstract: A weight data compression method includes: generating a 4-bit data string of 4-bit data items each expressed as any one of nine 4-bit values, by dividing ternary weight data into data items each having 4 bits; and generating first compressed data including a first flag value string and a first non-zero value string by (i) generating the first flag value string by assigning one of 0 and 1 as a first flag value of a 1-bit flag to a 4-bit data item 0000 and assigning an other of 0 and 1 as a second flag value of the 1-bit flag to a 4-bit data item other than 0000 among the 4-bit data items in the 4-bit data string and (ii) generating the first non-zero value string by converting the 4-bit data item other than 0000 into a 3-bit data item having any one of eight 3-bit values.

Abstract: A weight data compression method includes: generating a 4-bit data string of 4-bit data items each expressed as any one of nine 4-bit values, by dividing ternary weight data into data items each having 4 bits; and generating first compressed data including a first flag value string and a first non-zero value string by (0) generating the first flag value string by assigning one of 0 and 1 as a first flag value of a 1-bit flag to a 4-bit data item 0000 and assigning an other of 0 and 1 as a second flag value of the 1-bit flag to a 4-bit data item other than 0000 among the 4-bit data items in the 4-bit data string and (ii) generating the first non-zero value string by converting the 4-bit data item other than 0000 into a 3-bit data item having any one of eight 3-bit values.

Abstract: A memory access control unit is provided with a storage unit for storing a page table that stores a correspondence between a piece of data, a virtual page number, and a physical page number for all pages, and a conversion unit that includes a buffer for storing, for each of a subset of the pages, the virtual page number and the physical page number in correspondence, and a conversion processing unit operable to convert a virtual address into a physical address in accordance with content stored in the buffer.

Abstract: A harmonic suppression resonator comprises a plurality of waveguide resonators that resonate in TE mode, in which harmonic suppression resonator, adjoining resonators are coupled via a plurality of coupling windows. Four coupling windows 33bc1, 33bc2, 33bc3 and 33bc4 are provided between a resonant region 51b and a resonant region adjoining the resonant region 51b. These coupling windows allow fundamental wave modes of the adjoining resonators to be coupled mainly by magnetically coupling. The coupling windows 33bc3 and 33bc4 allow second harmonic modes of the adjoining resonators to be electrically coupled, and the coupling windows 33bc1 and 33bc2 allow the second harmonic modes of the adjoining resonators to be magnetically coupled. By causing the amount of the electrically coupling and the amount of the magnetically coupling to be substantially equal, the coupling of the second harmonic modes is negated, whereby propagation of the second harmonic is blocked.

Abstract: A memory access control unit is provided with a storage unit for storing a page table that stores a correspondence between a piece of data, a virtual page number, and a physical page number for all pages, and a conversion unit that includes a buffer for storing, for each of a subset of the pages, the virtual page number and the physical page number in correspondence, and a conversion processing unit operable to convert a virtual address into a physical address in accordance with content stored in the buffer.

Abstract: A harmonic suppression resonator comprises a plurality of waveguide resonators that resonate in TE mode, in which harmonic suppression resonator, adjoining resonators are coupled via a plurality of coupling windows. Four coupling windows 33bc1, 33bc2, 33bc3 and 33bc4 are provided between a resonant region 51b and a resonant region adjoining the resonant region 51b. These coupling windows allow fundamental wave modes of the adjoining resonators to be coupled mainly by magnetically coupling. The coupling windows 33bc3 and 33bc4 allow second harmonic modes of the adjoining resonators to be electrically coupled, and the coupling windows 33bc1 and 33bc2 allow the second harmonic modes of the adjoining resonators to be magnetically coupled. By causing the amount of the electrically coupling and the amount of the magnetically coupling to be substantially equal, the coupling of the second harmonic modes is negated, whereby propagation of the second harmonic is blocked.

Abstract: The present invention allows a buffer memory to be shared for data streams, while maintaining space efficiency of the buffer memory. A buffer memory sharing apparatus allowing the buffer memory to be shared includes: a flag managing circuit which manages flags each indicating an occupancy status of a region; and, for the each data stream, an address generating circuit. The address generating circuit includes: an occupancy managing circuit which manages exclusive allocation of regions based on the flags; a FIFO memory which stores a bit sequence indicating an allocated region; a write counter; and a read counter. The address generating circuit generates a write address by combining a bit sequence stored at an end of the FIFO memory and a value of the write counter, and generates a read address by combining a bit sequence stored at a start of the FIFO memory and a value of the read counter.

Abstract: A composition that effectively prevents the manifestation of osteoporosis, the formation of osteoclasts and suppresses a decrease of spongy bone density. The composition primarily contains Cordyceps sinensis or its processed product.

Abstract: Compositions and methods for treating osteoporosis, the formation of osteoeclasts, and/or for the suppression of decreasing spongy bone density. Example methods include administering Cordyceps sinensis or its processed product.

Abstract: The present invention provides a composition that effectively prevents the manifestation of osteoporosis, the formation of osteoclasts and the suppression of decreasing spongy bone density. The composition primarily contains Cordyceps Sinensis or its processed product.

Abstract: The present invention provides a composition that effectively presents the manifestation of osteoporosis, the formation of osteoclasts and the suppression of decreasing spongy bone density. The composition primarily contains Cordyceps Sinensis or its processed product.

Abstract: Disclosed is a holder for sealing member, in which at least a portion of the holder which comes into contact with the member comprises a sintered body comprising as a main component a non-oxide ceramic of silicon nitride, aluminum nitride, sialon or silicon carbide.By the use of the holder according to this invention, in the hermetic sealing process which is carried out continuously and automatically, an exchange frequency of the holder can be decreased remarkably, and thus a working efficiency on a manufacturing line can be increased. In consequence, the holder according to this invention is industrially very useful, and in particular, it is suitable for the hermetic sealing of the panel pins for cathode ray tubes.

Abstract: There is provided a fat emulsion of an ester of flurbiprofen having the formula ##STR1## wherein R is a group of the formula ##STR2## wherein R.sub.1 is a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group, R.sub.2 is a C.sub.1 -C.sub.15 alkyl group or a C.sub.2 -C.sub.8 alkenyl group, and m is zero or an integer of 1; or a lactone group of the formula ##STR3## wherein R.sub.3 and R.sub.4 are same as or different from each other and are a hydrogen atom or a C.sub.1 -C.sub.3 alkyl group, and n is an integer of 1 or 2.The emulsion containing particles of a vegetable oil dissolving the ester can be orally or parenterally administered to human or animal for analgesia, antiphlogosis and antipyresis in various diseases and exhibits a high activity with small amounts in terms of flurbiprofen as compared with flurbiprofen itself.

Abstract: A method for regulating the bone metabolism of a warm-blooded animal, which comprises administering pharmaceutically effective amounts of 1.alpha., 24-dihydroxycholecalciferol (1.alpha., 24-DHCC) and 24,25-dihydroxycholecalciferol (24,25-DHCC) to said warm-blooded animal, and a pharmaceutical composition comprising 1.alpha.,24-DHCC, 24,25-DHCC and a pharmaceutically acceptable carrier.According to the invention, a condition of abnormal bone metabolism requiring long-term therapy, such as osteoporosis, can be safely treated by administering 1.alpha., 24-DHCC and 24,25-DHCC over a long period of time because no substantial adverse effect of 1.alpha., 24-DHCC on the metabolis of 24,25-DHCC is observed.

Abstract: This is a bone formation stimulant containing vitamin D.sub.3 or its derivative and acetylsalicylic acid or its formaceutically permissible salt. The present bone formation stimulant is used to cure or prevent the diseases caused by the deficiency of vitamin D or related diseases by dosing human beings or animals with it.

Abstract: Organothiocyclopentanes of the formula ##STR1## wherein E represents >C.dbd.O or ##STR2## in which Z' represents a hydrogen atom, a hydroxyl group or a protected hydroxyl group; X represents --S--, --CH.sub.2 --, --CH.dbd.; represents a single or double bond; R' represents a monovalent or divalent organic group containing 1 to 25 carbon atoms; R represents a monovalent organic group containing 1 to 25 carbon atoms; Z represents a hydrogen atom, a hydroxyl group or a protected hydroxyl group; and when both E and Z represent a hydroxyl group or a protected hydroxyl group, X represents --S--.Also, 2-organothio-2-cyclopentenones of the formula ##STR3## wherein R and Z are as defined above. The compounds of formula (I) are prepared by reacting 2,3-epoxy-cyclopentanone or its derivatives with mercaptans in the presence of basic compounds.

Abstract: Novel 4H-pyrrolo[1,2-a][1,4]benzodiazepine derivatives of the formula ##STR1## wherein at least one of R.sub.1, R.sub.2 and R.sub.3 represent lower alkyl and the remainder hydrogen, R.sub.4 represents hydrogen or lower alkyl, ring A optionally contains at least one substituent selected from halogen, nitro and trifluoromethyl, and ring B optionally contains at least one substituent selected from halogen, nitro, trifluoromethyl, lower alkyl and lower alkoxy; and novel intermediates thereof expressed by the formula ##STR2## wherein Z represents protected amino. Compounds of formula (I) are prepared by subjecting compounds of formula (II) to protective group-elimination and cyclization. The compounds of formula (I) and acid addition salts thereof have useful anti-anxietic, sedative, anti-convulsant, muscle relaxant and hypnotic, and their toxicity is low.

Abstract: Novel 1.alpha., 24-dihydroxycholecalciferol and derivatives thereof which are useful with reduced side-effects for the treatment of abnormal metabolism of calcium and phosphorus caused by liver failure, renal failure, gastrointestinal tract failure and parathyroid failure, and related bone diseases. Preparation of the novel 1.alpha., 24-dihydroxycholecalciferol and their derivatives starts from 1.alpha., 24-dihydroxycholesterol prepared by reacting 1.alpha., 2.alpha.-epoxy-24-keto-cholesta-4,6-dien-3-one with an alkali metal and a proton donor in the presence of liquid ammonia or a liquid amine. Reaction of the 1.alpha., 24-dihydroxycholesterol with an allylic brominating agent, followed by contacting with a dehydrobrominating agent, affords 1.alpha.,3.beta., 24-trihydroxycholesta-5,7-diene derivative, which can then be converted to 1.alpha., 24-dihydroxycholocalciferol by ultraviolet irradiation in a organic solvent, followed by isomerization. Processes are also provided for separating 1.alpha.

Abstract: The thioallophanate compound represented by the following general formula ##EQU1## wherein X is hydrogen, chlorine atom, nitro or methyl group: Z is a substituting group selected from the group consisting of ##EQU2## and ##EQU3## has excellent anthelmintic activity and can be used for controlling helminthiasis of animals.